ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,726, issued on Oct. 28, was assigned to Novartis AG (Basel, Switzerland).
"Methods of using factor B inhibitors" was invented by Irina Baltcheva (Oberwil, Switzerland), Peter End (Oberwil, Switzerland) and Julie Marie-Pomme Gabrielle Milojevic (Village Neuf, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods of treating paroxysmal nocturnal hemoglobinuria (PNH) with the Factor B inhibitor LNP023 or a pharmaceutically acceptable salt thereof, e.g. LNP023 hydrochloride."
The patent was filed on March 5, 2024, under Application No. 18/595,759.
*For further information, including images, charts and tables, please visit:...